Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yolande Lievens

Showing results (11-20 of 181) with videos related to

Pageof 19
Sort By:
Seminars in Radiation Oncology|March 12, 2013
Health economic controversy and cost-effectiveness of proton therapyYolande Lievens, Madelon Pijls-Johannesma
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 14, 2005
Proton beam therapy: too expensive to become true?Yolande Lievens, Walter Van den Bogaert
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 12, 2020
Feasibility and impact of national peer reviewed clinical audits in radiotherapy departmentsAude Vaandering, Yolande Lievens, Pierre Scalliet, et al.
The Lancet. Oncology|October 1, 2015
Expanding global access to radiotherapy: the European Society for Radiotherapy and Oncology perspectivePhilip Poortmans, Vincenzo Valentini, Yolande Lievens
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 16, 2010
Radiotherapy in early stage Hodgkin's lymphoma: The importance of volume and treatment positionBart Reymen, Sylvie Spiessens, Yolande Lievens
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 22, 2002
Internal mammary and medial supraclavicular lymph node irradiation: the thin line between advantages and side effectsYolande Lievens, Walter Van den Bogaert
Acta Oncologica (Stockholm, Sweden)|August 6, 2019
Value-based health care - what does it mean for radiotherapy?Yolande Lievens, Cai Grau, Ajay Aggarwal
Acta Oncologica (Stockholm, Sweden)|July 23, 2015
Cost calculation: a necessary step towards widespread adoption of advanced radiotherapy technologyYolande Lievens, Jose Maria Borras, Cai Grau
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2008
Cost-effectiveness of particle therapy: current evidence and future needsMadelon Pijls-Johannesma, Pascal Pommier, Yolande Lievens
Acta Oncologica (Stockholm, Sweden)|July 28, 2015
The need for radiotherapy in Europe in 2020: Not only data but also a cancer planJosep M Borras, Yolande Lievens, Cai Grau
Pageof 19

Showing results (11-20 of 181) with videos related to

Sort By:
Pageof 19
Seminars in Radiation Oncology|March 12, 2013
Health economic controversy and cost-effectiveness of proton therapyYolande Lievens, Madelon Pijls-Johannesma
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 14, 2005
Proton beam therapy: too expensive to become true?Yolande Lievens, Walter Van den Bogaert
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 12, 2020
Feasibility and impact of national peer reviewed clinical audits in radiotherapy departmentsAude Vaandering, Yolande Lievens, Pierre Scalliet, et al.
The Lancet. Oncology|October 1, 2015
Expanding global access to radiotherapy: the European Society for Radiotherapy and Oncology perspectivePhilip Poortmans, Vincenzo Valentini, Yolande Lievens
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 16, 2010
Radiotherapy in early stage Hodgkin's lymphoma: The importance of volume and treatment positionBart Reymen, Sylvie Spiessens, Yolande Lievens
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 22, 2002
Internal mammary and medial supraclavicular lymph node irradiation: the thin line between advantages and side effectsYolande Lievens, Walter Van den Bogaert
Acta Oncologica (Stockholm, Sweden)|August 6, 2019
Value-based health care - what does it mean for radiotherapy?Yolande Lievens, Cai Grau, Ajay Aggarwal
Acta Oncologica (Stockholm, Sweden)|July 23, 2015
Cost calculation: a necessary step towards widespread adoption of advanced radiotherapy technologyYolande Lievens, Jose Maria Borras, Cai Grau
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2008
Cost-effectiveness of particle therapy: current evidence and future needsMadelon Pijls-Johannesma, Pascal Pommier, Yolande Lievens
Acta Oncologica (Stockholm, Sweden)|July 28, 2015
The need for radiotherapy in Europe in 2020: Not only data but also a cancer planJosep M Borras, Yolande Lievens, Cai Grau
Pageof 19